“I will not be apologizing,” I said. “Today, I formally resign from my domestic executive role to assume the position of Regional Managing Director for North America, based in New York.”
The room went still.
Daniel laughed sharply. “You can’t do that without my approval.”
“That’s incorrect,” I replied, sliding the folder forward. “The board approved this expansion three weeks ago. Contracts were finalized last night.”
Directors opened the documents. William avoided Daniel’s gaze.
I outlined the growth strategy I had built over a year—partnerships with major research hospitals, renewed focus on rare autoimmune diseases, and a long-term pipeline aligned with the company’s founding values.
Then I addressed the silence.
“There are compliance issues,” I said. “Misuse of R&D funds, undisclosed conflicts, and pressure to suppress unfavorable findings.”
Lauren stiffened. Daniel stopped smiling.
“I’ve submitted full documentation to the ethics committee,” I added. “They’ll proceed accordingly.”
There was no shouting. Just finality.
By the meeting’s end, my transition timeline was approved. New York wanted me immediately.
Daniel confronted me afterward, furious.
“You planned this.”